CUVL (CUVL)
5.90
0.00 (0.00%)
Latest Headlines
Form 6-K Clinuvel Pharmaceuticals For: Aug 27
August 27, 2026 11:37 AM - SEC Filing
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
August 27, 2026 1:42 AM - Globe NewsWire
Form 6-K Clinuvel Pharmaceuticals For: Aug 20
August 20, 2026 6:08 AM - SEC Filing
Form 6-K Clinuvel Pharmaceuticals For: Aug 12
August 12, 2026 6:06 AM - SEC Filing
Form 6-K Clinuvel Pharmaceuticals For: Jul 30
July 30, 2026 6:10 AM - SEC Filing
Form 6-K Clinuvel Pharmaceuticals For: Jul 28
July 28, 2026 6:06 AM - SEC Filing
Form 6-K Clinuvel Pharmaceuticals For: Jul 27
July 27, 2026 2:22 PM - SEC Filing
Form 6-K Clinuvel Pharmaceuticals For: Jul 23
July 23, 2026 3:21 PM - SEC Filing
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
July 23, 2026 12:10 AM - Globe NewsWire
Form 6-K Clinuvel Pharmaceuticals For: Jul 21
July 22, 2026 6:04 AM - SEC Filing
Form 6-K Clinuvel Pharmaceuticals For: Jul 21
July 22, 2026 6:04 AM - SEC Filing
CLINUVEL’s ADS to commence trading on Nasdaq
July 20, 2026 1:37 AM - Globe NewsWire
Full Article List